|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities | |||
| Stock-based compensation | |||
| Depreciation | |||
| Amortization of discount on debt and interest income | |||
| Depreciation and amortization | |||
| Revaluation of warrant liabilities | |||
| Allowance for doubtful accounts | |||
| Other | |||
| Changes in operating assets and liabilities, net of business acquisition | |||
| Accounts receivable | |||
| Inventory | |||
| Deferred cost of revenue | |||
| Deferred commissions | |||
| Prepaid expenses and other current assets | |||
| Other assets | |||
| Accounts payable | |||
| Accrued compensation | |||
| Accrued expenses | |||
| Customer deposits | |||
| Severance pay, net | |||
| Deferred revenue | |||
| Other liabilities | |||
| Net cash (used in) provided by operating activities | |||
| Cash flows from investing activities | |||
| Purchases of property and equipment | |||
| Change in restricted cash | |||
| Purchases of marketable securities | |||
| Proceeds from maturities of marketable securities | |||
| Proceeds from sales of marketable securities | |||
| Business acquisition, net of cash acquired | |||
| Net cash provided by (used in) investing activities | |||
| Cash flows from financing activities | |||
| Net borrowings of notes payable | |||
| Payment of accrued success fees | |||
| Proceeds from issuance of redeemable convertible preferred stock upon exercise of warrants | |||
| Proceeds from exercise of stock options | |||
| Repurchase of unvested common stock | |||
| Net proceeds from issuance of redeemable convertible preferred stock | |||
| Proceeds from sales of shares through employee equity incentive plans | |||
| Payment related to shares withheld for taxes on vesting of restricted stock units | |||
| Payments of deferred offering costs | |||
| Proceeds from public offering, net of underwriting discounts and commissions | |||
| Others | |||
| Net cash provided by financing activities | |||
| Net change in cash and cash equivalents for period | |||
| Cash and cash equivalents | |||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||
| Net change in cash, cash equivalents, and restricted cash for period | |||
| Cash, cash equivalents, and restricted cash at beginning of period | |||
| Cash, cash equivalents, and restricted cash at end of period | |||
| Supplemental disclosure of cash flow information: | |||
| Cash paid for income taxes | |||
| Cash paid for interest | |||
| Noncash disclosure of investing and financing activities: | |||
| Change in liability for early exercise of stock options, net of vested portion | |||
| Costs related to issuance of redeemable convertible preferred stock in accrued expenses | |||
| Leasehold improvements paid by lessor | |||
| Purchases of property and equipment recorded in accounts payable and accrued expenses | |||
| Deferred offering costs included in accrued expenses | |||
| Unrealized loss on marketable securities | |||
| Conversion of preferred stock warrants to common stock warrants in connection with initial public offering | |||
| Cashless exercise of preferred stock warrants | |||
| Leased assets obtained in exchange for new operating lease liabilities | |||
| Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the statements of cash flows above: | |||
| Cash and cash equivalents | |||
| Restricted cash included in prepaid expenses and other current assets | |||
| Restricted cash - non-current |
Loading...